Press Releases

Micro-Sphere Expands HPAPI Capabilities at Swiss Site

Spray drying specialist and capsule filling service contract development and manufacturing organisation (CDMO) Micro-Sphere has invested over €5 million to expand its GMP manufacturing capabilities at its facility in Monteggio, Switzerland.

Calyx IRT Delivers Flexibility to Accelerate Recruitment

Advanced IRT system enhanced with self-service functionality to quickly address trial challenges

Polio vaccination efforts must be supported by good hygiene, say experts on World Polio Day

RGHI raise awareness for good hygiene on World Polio Day 24th October

Creative BioMart Helps Brighten Up Cell Surface Display Research with Advanced Platforms

Profacgen Established a GMP Grade Stable Cell Line Development System for Research Use

INCOG BioPharma Primes Multi-Use Filling Line for Launch

About INCOG BioPharma Services Designed to deliver better. Discover the INCOG way. We designed and built INCOG BioPharma based on decades of experience with a clear purpose: to deliver better CDMO services in the injectable drug product space. The company’s service offering includes filling drug product into vials, syringes, and cartridges. INCOG BioPharma also offers support services to include formulation development, analytical development, stability testing and storage, and final inspection, labeling, packaging, and device assembly. With our dedicated team, best-in-class processes, and state-of-the-art equipment, we deliver meaningful results and stand-out customer experiences. We stand behind our motto, “in it with you,” from the moment we start work on your project. We go above and beyond to understand your requirements, meet your needs, and foster a truly collaborative partnership. For more information, visit www.incogbiopharma.com and follow us at INCOG BioPharma Services on LinkedIn.

Navignostics Selects Celegence's CAPTIS™ Technology Solution to Support IVDR Compliance

Celegence, a global provider of regulatory affairs services for the life sciences industry, is pleased to announce that Navignostics, a global developer of drug mechanisms designed to identify ideal treatments for cancer patients, has selected Celegence’s CAPTIS™ technology solution to support Performance Evaluation Reports and other PMS documentation in compliance with the In-Vitro Diagnostic Regulation (IVDR).

Ardena announces major expansion plans for Swedish site

The expansion will increase development and manufacturing for small molecules at the Södertälje facility with new equipment and increased capabilities to strengthen the firm’s existing expertise in drug substance manufacture.

A Robust Telomere Aging Clocks Platform Helps Conduct Lab-Grade Telomere Length Analysis

A robust telomere aging clocks system combined with RF, qPCR, STELA, and TESLA techniques is newly reconfigured to conduct specialized lab-grade telomere length analysis and offer comprehensive pictures of biological aging.

NDA Group is pleased to announce the expansion of the NDA Advisory Board with the appointment of Sigrid Klaar M.D., Ph.D., specialist in oncology

NDA Group has announced the expansion of the NDA Advisory Board with the appointment of Sigrid Klaar M.D., Ph.D., specialist in oncology.

Tillotts Pharma AG announces the launch of Octasa® 800mg Tablets in Canada

Tillotts Pharma AG has announced the recent launch of Octasa® 800mg (mesalazine) delayed-release tablets, as first-line treatment for moderately active ulcerative colitis (UC) in Canada.

Recipharm strengthens pre-filled syringe and cartridge offering with new investment

END Contact information For media enquiries, please contact Imogen Quail, PR Manager, at ramarketing: imogen.quail@ramarketingpr.com, +44 (0)191 222 1242, ramarketingpr.com, Twitter: @ramarketingpr, Facebook: /ramarketingpr, LinkedIn: /ramarketing About Recipharm Recipharm is a leading Contract Development and Manufacturing Organisation (CDMO) in the pharmaceutical industry employing almost 9,000 employees. Recipharm offers manufacturing services of pharmaceuticals in various dosage forms, production of clinical trial material and APIs, pharmaceutical product development and development and manufacturing of medical devices. Recipharm manufactures several hundred different products to customers ranging from big pharma to smaller research and development companies. The company operates development and manufacturing facilities in France, Germany, India, Israel, Italy, Portugal, Spain, Sweden, the UK and the US and is headquartered in Stockholm, Sweden. For more information on Recipharm and our services, please visit www.recipharm.com 1Source Safety Prefilled Syringe Market Size is expected to reach (globenewswire.com) Recipharm AB Corporate identity number 556498-8425 Address Box 603, SE-101 32 Stockholm, Sweden, Telephone +46 8 602 52 00 www.recipharm.com

Biopharma PEG Provides Large Scale PEG Derivatives Applied In The Pharmaceutical Industry

Creative Diagnostics Launches Monkeypox Virus Antigens and Antibodies to Accelerate MPXV Study

Creative Diagnostics announced the launch of Monkeypox Virus Antigens and Antibodies to support scientists focused on the research of monkeypox virus.

Amerigo Scientific Launches PicoRaman Spectrometer for Time-resolved Measurements

Amerigo Scientific recently announced the launch of its new PicoRaman Spectrometer for biological and pharmaceutical applications.

STEMart Launches Biological Indicator Sterility Testing Service for Medical Devices

STEMart has recently introduced Biological Indicator Sterility Testing services for the industry of medical devices.

Cytel to acquire SDS Life Science and SDS MedteQ to enhance and expand thought-leadership in strategic therapeutic development

ytel Inc. has entered into an agreement to acquire SDS Life Science AB and SDS MedteQ AB.

Samsung Biologics obtains three global ISO certifications

Samsung Biologics (KRX: 207940.KS), a leading contract development and manufacturing organization (CDMO), announced today it has successfully renewed its ISO 27001 certification (Information Security Management System) and obtained ISO 27017 certification (Information Security in cloud services) and ISO 37001 certification (Anti-bribery management systems).

CDMO Services Released by Alfa Chemistry Offer New Possibilities for Pharmaceutical Development & Manufacturing

Known for its competence, responsibility, and innovative capability in chemical supply, Alfa Chemistry recently unveiled its new role as a CDMO service provider for pharmaceutical companies worldwide.

Celegence unveils next level efficiencies for eCTD compliance with new functionality added to Dossplorer™

New functionality added to advanced dossier management solution to bring greater efficiencies to eCTD compliance